Arginine deprivation and tumour cell death: arginase and its inhibition

Denis Wheatley, R. Philip, E. Campbell

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Arginase treatment of cell cultures reduced arginine in the medium to similar to micromolar levels within 5-30 min, and proved as effective as arginine-free medium (AFM) prepared by formulation. The enzyme was heat stable and as active at pH 7.2 as at pH 9.9. It persisted in culture for at least 3 days with only a small diminution in its speed of action, and still actively destroyed arginine after 6 days, since arginine supplementation failed to rescue viable cells.

    Addition of L-norvaline, an inhibitor of arginase, rescued cells from arginase-induced deprivation. Its efficacy at low concentrations was short-lived (probably < 1 day), while at higher concentrations it did not appear to inhibit completely the enzyme. However, L-norvaline at these same levels also slowed the growth of positive non-enzyme treated controls receiving the normal arginine level. Thus the difference in this growth indicated that arginase was more inhibitory than cursory examination of initial kinetic data suggested. It also agreed with the inhibition of arginase in the ornithine assay used to measure biochemically enzyme activity. We conclude that norvaline partially but not completely antagonises arginase activity, which allows cell rescue in a dose-dependent manner between 0.4 and 4 mM, but cannot be used above about 2 mM without exhibiting a general non-specific interference of cell growth of its own, although no evidence of cell toxicity was observed in either AFM or arginine-containing medium. L-ornithine, the product of arginase that inhibits the enzyme by a feedback mechanism, had no inhibitory effect on arginase over a similar concentration range.

    Original languageEnglish
    Pages (from-to)177-185
    Number of pages8
    JournalMolecular & Cellular Biochemistry
    Volume244
    Issue number1-2
    DOIs
    Publication statusPublished - 2003

    Keywords

    • cancer
    • arginine
    • arginase
    • norvaline
    • ornithine
    • deprivation
    • catabolism
    • cell proliferation
    • cell death
    • HUMAN-DIPLOID FIBROBLASTS
    • DEIMINASE
    • GROWTH
    • LEUKEMIA

    Cite this

    Arginine deprivation and tumour cell death: arginase and its inhibition. / Wheatley, Denis; Philip, R.; Campbell, E.

    In: Molecular & Cellular Biochemistry, Vol. 244, No. 1-2, 2003, p. 177-185.

    Research output: Contribution to journalArticle

    Wheatley, Denis ; Philip, R. ; Campbell, E. / Arginine deprivation and tumour cell death: arginase and its inhibition. In: Molecular & Cellular Biochemistry. 2003 ; Vol. 244, No. 1-2. pp. 177-185.
    @article{4fe3a36e1baf4fb6b45a7f5c12162773,
    title = "Arginine deprivation and tumour cell death: arginase and its inhibition",
    abstract = "Arginase treatment of cell cultures reduced arginine in the medium to similar to micromolar levels within 5-30 min, and proved as effective as arginine-free medium (AFM) prepared by formulation. The enzyme was heat stable and as active at pH 7.2 as at pH 9.9. It persisted in culture for at least 3 days with only a small diminution in its speed of action, and still actively destroyed arginine after 6 days, since arginine supplementation failed to rescue viable cells.Addition of L-norvaline, an inhibitor of arginase, rescued cells from arginase-induced deprivation. Its efficacy at low concentrations was short-lived (probably < 1 day), while at higher concentrations it did not appear to inhibit completely the enzyme. However, L-norvaline at these same levels also slowed the growth of positive non-enzyme treated controls receiving the normal arginine level. Thus the difference in this growth indicated that arginase was more inhibitory than cursory examination of initial kinetic data suggested. It also agreed with the inhibition of arginase in the ornithine assay used to measure biochemically enzyme activity. We conclude that norvaline partially but not completely antagonises arginase activity, which allows cell rescue in a dose-dependent manner between 0.4 and 4 mM, but cannot be used above about 2 mM without exhibiting a general non-specific interference of cell growth of its own, although no evidence of cell toxicity was observed in either AFM or arginine-containing medium. L-ornithine, the product of arginase that inhibits the enzyme by a feedback mechanism, had no inhibitory effect on arginase over a similar concentration range.",
    keywords = "cancer, arginine, arginase, norvaline, ornithine, deprivation, catabolism, cell proliferation, cell death, HUMAN-DIPLOID FIBROBLASTS, DEIMINASE, GROWTH, LEUKEMIA",
    author = "Denis Wheatley and R. Philip and E. Campbell",
    year = "2003",
    doi = "10.1023/A:1022451705701",
    language = "English",
    volume = "244",
    pages = "177--185",
    journal = "Molecular & Cellular Biochemistry",
    issn = "0300-8177",
    publisher = "Springer Netherlands",
    number = "1-2",

    }

    TY - JOUR

    T1 - Arginine deprivation and tumour cell death: arginase and its inhibition

    AU - Wheatley, Denis

    AU - Philip, R.

    AU - Campbell, E.

    PY - 2003

    Y1 - 2003

    N2 - Arginase treatment of cell cultures reduced arginine in the medium to similar to micromolar levels within 5-30 min, and proved as effective as arginine-free medium (AFM) prepared by formulation. The enzyme was heat stable and as active at pH 7.2 as at pH 9.9. It persisted in culture for at least 3 days with only a small diminution in its speed of action, and still actively destroyed arginine after 6 days, since arginine supplementation failed to rescue viable cells.Addition of L-norvaline, an inhibitor of arginase, rescued cells from arginase-induced deprivation. Its efficacy at low concentrations was short-lived (probably < 1 day), while at higher concentrations it did not appear to inhibit completely the enzyme. However, L-norvaline at these same levels also slowed the growth of positive non-enzyme treated controls receiving the normal arginine level. Thus the difference in this growth indicated that arginase was more inhibitory than cursory examination of initial kinetic data suggested. It also agreed with the inhibition of arginase in the ornithine assay used to measure biochemically enzyme activity. We conclude that norvaline partially but not completely antagonises arginase activity, which allows cell rescue in a dose-dependent manner between 0.4 and 4 mM, but cannot be used above about 2 mM without exhibiting a general non-specific interference of cell growth of its own, although no evidence of cell toxicity was observed in either AFM or arginine-containing medium. L-ornithine, the product of arginase that inhibits the enzyme by a feedback mechanism, had no inhibitory effect on arginase over a similar concentration range.

    AB - Arginase treatment of cell cultures reduced arginine in the medium to similar to micromolar levels within 5-30 min, and proved as effective as arginine-free medium (AFM) prepared by formulation. The enzyme was heat stable and as active at pH 7.2 as at pH 9.9. It persisted in culture for at least 3 days with only a small diminution in its speed of action, and still actively destroyed arginine after 6 days, since arginine supplementation failed to rescue viable cells.Addition of L-norvaline, an inhibitor of arginase, rescued cells from arginase-induced deprivation. Its efficacy at low concentrations was short-lived (probably < 1 day), while at higher concentrations it did not appear to inhibit completely the enzyme. However, L-norvaline at these same levels also slowed the growth of positive non-enzyme treated controls receiving the normal arginine level. Thus the difference in this growth indicated that arginase was more inhibitory than cursory examination of initial kinetic data suggested. It also agreed with the inhibition of arginase in the ornithine assay used to measure biochemically enzyme activity. We conclude that norvaline partially but not completely antagonises arginase activity, which allows cell rescue in a dose-dependent manner between 0.4 and 4 mM, but cannot be used above about 2 mM without exhibiting a general non-specific interference of cell growth of its own, although no evidence of cell toxicity was observed in either AFM or arginine-containing medium. L-ornithine, the product of arginase that inhibits the enzyme by a feedback mechanism, had no inhibitory effect on arginase over a similar concentration range.

    KW - cancer

    KW - arginine

    KW - arginase

    KW - norvaline

    KW - ornithine

    KW - deprivation

    KW - catabolism

    KW - cell proliferation

    KW - cell death

    KW - HUMAN-DIPLOID FIBROBLASTS

    KW - DEIMINASE

    KW - GROWTH

    KW - LEUKEMIA

    U2 - 10.1023/A:1022451705701

    DO - 10.1023/A:1022451705701

    M3 - Article

    VL - 244

    SP - 177

    EP - 185

    JO - Molecular & Cellular Biochemistry

    JF - Molecular & Cellular Biochemistry

    SN - 0300-8177

    IS - 1-2

    ER -